134 related articles for article (PubMed ID: 7583564)
1. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
[TBL] [Abstract][Full Text] [Related]
3. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
[TBL] [Abstract][Full Text] [Related]
4. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
[TBL] [Abstract][Full Text] [Related]
5. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
Yamashita S; Hirano K; Sakai N; Matsuzawa Y
Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
[TBL] [Abstract][Full Text] [Related]
6. Point mutation (-69 G-->A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
Nagano M; Yamashita S; Hirano K; Kujiraoka T; Ito M; Sagehashi Y; Hattori H; Nakajima N; Maruyama T; Sakai N; Egashira T; Matsuzawa Y
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):985-90. PubMed ID: 11397708
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
[TBL] [Abstract][Full Text] [Related]
8. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
Arai T; Yamashita S; Sakai N; Hirano K; Okada S; Ishigami M; Maruyama T; Yamane M; Kobayashi H; Nozaki S; Funahashi T; Kameda-Takemura K; Nakajima N; Matsuzawa Y
J Lipid Res; 1996 Oct; 37(10):2145-54. PubMed ID: 8906592
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
Nagano M; Yamashita S; Hirano K; Takano M; Maruyama T; Ishihara M; Sagehashi Y; Kujiraoka T; Tanaka K; Hattori H; Sakai N; Nakajima N; Egashira T; Matsuzawa Y
J Atheroscler Thromb; 2004; 11(3):110-21. PubMed ID: 15256762
[TBL] [Abstract][Full Text] [Related]
10. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia.
Hirano K; Yamashita S; Funahashi T; Sakai N; Menju M; Ishigami M; Hiraoka H; Kameda-Takemura K; Tokunaga K; Hoshino T
Atherosclerosis; 1993 Apr; 100(1):85-90. PubMed ID: 8318066
[TBL] [Abstract][Full Text] [Related]
11. Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity.
Sich D; Saïdi Y; Giral P; Lagrost L; Egloff M; Auer C; Gautier V; Turpin G; Beucler I
Metabolism; 1998 Aug; 47(8):965-73. PubMed ID: 9711993
[TBL] [Abstract][Full Text] [Related]
12. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
Inano K; Miida T; Okada M
Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two HDL subfractions and LpA-I, LpA-I:A-II distribution profiles and clinical characteristics of hyperalphalipoproteinemic subjects without cholesterol ester transfer protein deficiency.
Sich D; Saïdi Y; Giral P; Lagrost L; Dallongeville J; Federspiel MC; Cherfils C; Raisonnier A; Turpin G; Beucler I
Atherosclerosis; 1998 Jun; 138(2):351-60. PubMed ID: 9690919
[TBL] [Abstract][Full Text] [Related]
14. Resequencing CETP, LIPC and LIPG genes in Thai subjects with hyperalphalipoproteinemia.
Khovidhunkit W; Chartyingcharoen P; Siriwong S; Limumpornpetch P; Plengpanich W
Am J Cardiol; 2012 Jul; 110(1):62-6. PubMed ID: 22464213
[TBL] [Abstract][Full Text] [Related]
15. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity.
Hirano K; Matsuzawa Y; Sakai N; Hiraoka H; Nozaki S; Funahashi T; Yamashita S; Kubo M; Tarui S
Metabolism; 1992 Dec; 41(12):1313-8. PubMed ID: 1461137
[TBL] [Abstract][Full Text] [Related]
16. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia.
Plengpanich W; Siriwong S; Khovidhunkit W
Metabolism; 2009 Aug; 58(8):1178-84. PubMed ID: 19428034
[TBL] [Abstract][Full Text] [Related]
17. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.
Sakai N; Yamashita S; Hirano K; Menju M; Arai T; Kobayashi K; Ishigami M; Yoshida Y; Hoshino T; Nakajima N
Atherosclerosis; 1995 Apr; 114(2):139-45. PubMed ID: 7605382
[TBL] [Abstract][Full Text] [Related]
18. Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity.
Arai T; Yamashita S; Hirano K; Sakai N; Kotani K; Fujioka S; Nozaki S; Keno Y; Yamane M; Shinohara E
Arterioscler Thromb; 1994 Jul; 14(7):1129-36. PubMed ID: 8018669
[TBL] [Abstract][Full Text] [Related]
19. Bimodal distribution of cholesteryl ester transfer protein activities in normotriglyceridemic men with low HDL cholesterol concentrations.
Tato F; Vega GL; Grundy SM
Arterioscler Thromb Vasc Biol; 1995 Apr; 15(4):446-51. PubMed ID: 7749855
[TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians.
van der Steeg WA; Hovingh GK; Klerkx AH; Hutten BA; Nootenboom IC; Levels JH; van Tol A; Dallinga-Thie GM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA
J Lipid Res; 2007 Mar; 48(3):674-82. PubMed ID: 17192423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
